The Parker Institute for Cancer Immunotherapy Awards More Than $1 Million to Four Early Career Investigators

SAN FRANCISCO–(BUSINESS WIRE)–The Parker Institute for Cancer Immunotherapy (PICI), a collaborative consortium of the world’s leading immuno-oncology experts, today named its 2024 class of Early Career Researcher awardees who are poised to redefine what is possible in cancer research. This year’s awardees will receive over $1 million in total to support their pioneering immunotherapy research, exploring promising approaches involving gene networks, synthetic receptors, metastatic stem cells a
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks